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The expressions of inflammatory factors and tissue 
inhibitor of matrix metalloproteinase-2 in human 
chronic periodontitis with type 2 diabetes mellitus
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Department of Periodontology, Kyungpook National University School of Dentistry, Daegu, Korea
Purpose:  The purpose of this study was to observe and quantify the expression of interleukin-4 (IL-4), interferon-g (IFN-g), and 
tissue inhibitor of matrix metalloproteinase-2 (TIMP-2) in the gingival tissue of patients with type 2 diabetes mellitus (DM) 
and healthy adults with chronic periodontitis.
Methods:  Twelve patients with type 2 DM and chronic periodontitis (Group 3), twelve patients with chronic periodontitis 
(Group 2), and twelve healthy individuals (Group 1) were included in the study. Clinical criteria of gingival (sulcus bleeding in-
dex value, probing depths) and radiographic evidences of bone resorption were divided into three groups. The concentrations 
of cytokines were determined by a western blot analysis and compared using one-way ANOVA followed by Tukey’s test.
Results:  The expression levels of IFN-g and TIMP-2 showed an increasing tendency in Groups 2 and 3 when compared to 
Group 1. On the other hand, the expression of IL-4 was highest in Group 1.
Conclusions:  The findings suggest that IFN-g and TIMP-2 may be involved in the periodontal inflammation associated with 
type 2 DM. IL-4 may be involved in the retrogression of the periodontal inflammation associated with type 2 DM.
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INTRODUCTION
Chronic periodontal diseases are bacterial infections affect-
ing the periodontium resulting in the loss of tooth support 
and are associated with bacteremia, inflammation, and a strong 
immune response. They represent primarily anaerobic Gram-
negative oral infection that leads to gingival inflammation, 
destruction of periodontal tissues and loss of alveolar bone [1,2].
Diabetes mellitus (DM) is a highly prevalent metabolic dis-
order. The more common form, type 2 diabetes, results from 
a combination of impaired insulin production and insulin re-
sistance [3].
The mechanisms responsible for these outcomes in patients 
with diabetes are mainly related to the increased risk of in-
fections, impairment of the synthesis of collagen and glycos-
aminoglycan by gingival fibroblasts, and increased collagenoly-
tic activity in crevicular fluid [4,5]. Patients with diabetes and 
periodontitis have enhanced production of inflammatory 
mediators in the gingival tissues compared to non-diabetics. 
These changes can contribute to the pathogenesis of periodon-
tal diseases and to alterations in wound healing because col-
lagen is the major structural protein in the periodontium [6,7].
The immune response against periodontopathic bacteria is 
regulated by the balance between cytokines produced by T 
helper 1 (Th1) and T helper 2 (Th2) cells. The typical secretory 
products of Th1 cells are interleukin (IL)-2, IL-12, tumor necro-
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sis factor (TNF)-b, and interferon (IFN)-g; those of Th2 cells 
are IL-4, IL-5, IL-6, IL-10, and IL-13 [8].
IL-4 is a glycosylated cytokine secreted by activated T lym-
phocyte, basophils and mast cells. It is a potent down-regula-
tor of macrophage function [9]. Furthermore IL-4 can down-
regulate the CD14 receptor and is also found to induce apop-
tosis in monocytes. IL-4 also inhibits the IL-1-induced expres-
sion of matrix metalloproteinase (MMP)-3 mRNA and pro-
tein in human gingival fibroblasts isolated from patients with 
periodontitis [10].
IFN-g is an antiviral and antiparasitic agent produced by 
CD4+/CD8+ lymphocytes and natural killer cells that under-
go activation by antigens or mitogens. IFN-g production mod-
ulates T cell growth and differentiation and inhibits the growth 
of B cells. Synthesis of IFN-g is inducible by IL-2, fibroblast 
growth factor, and epidermal growth factor. During the gen-
eration of a primary Th1 response, IFN-g acts as a positive reg-
ulator by selectively inducing Th1 differentiation through the 
increased transcription of T-bet, which results in enhanced 
IL-12 responsiveness and suppressed Th2 lineage commit-
ment [11]. In some studies [12,13], IFN-g seemed to be the pre-
dominant cytokine produced by T cells in periodontal dis-
eases, and an enhancement of IFN-g-producing cells was cor-
related with the progression of disease.
MMPs belong to the matrixin family, which is composed of 
at least 23 related zinc-dependent endopeptidases that are able 
to degrade extracellular matrix proteins [14].
Tissue inhibitor of matrix metalloproteinases (TIMPs), which 
consist of four members, TIMP-1, 2, 3, and 4, have many basic 
similarities, but they exhibit structural and biochemical dif-
ferences. These molecules inhibit the proteolytic activity of 
activated MMPs by forming 1:1 stochiometric inhibitory com-
plex with the enzyme [15]. The balance between activated 
MMPs and TIMPs controls the extent of extracellular matrix 
remodeling [16], and a disruption of the MMP-TIMP balance 
can result in pathological processes such as arthritis, athero-
sclerosis and periodontitis, in which the loss of extracellular 
matrix (ECM) is a major feature. TIMP-2 is also able to bind 
noncovalently to the latent proform of MMP-2 away from its 
active sites, thereby preventing its activation and inhibiting 
enzyme activity [17].
Cytokines are considered to play a key role in the inflam-
mation process [18]. In inflammatory response with bone re-
sorption, the role and interactions of IL-4, IFN-g and TIMP-2 
are not clear, and their relative contribution to the pathogen-
esis of periodontitis and alveolar bone resorption is not en-
tirely established yet. The purpose of this study was to observe 
and quantify the expression of IL-4, IFN-g, and TIMP-2 in the 
gingival tissue of patients with type 2 DM and systemically 
healthy adults with chronic periodontitis.
MATERIALS AND METHODS
Study population and tissue sampling
The study population consisted of 12 patients with type 2 
diabetes and chronic periodontitis (Group 3), 12 patients with 
chronic periodontitis (Group 2), and 12 healthy individuals 
(Group 1). Marginal gingival tissue samples were obtained by 
internal bevel incision at the time of periodontal surgery (in-
cluding surgical crown lengthening) or tooth extraction and 
informed consent was obtained from all of the participants 
before the surgery. This study was approved by the Ethical 
Committee of Clinical Experiments, Kyungpook National Uni-
versity (74005-1119).
Clinical criteria of gingiva (sulcus bleeding index value, prob-
ing depths) and radiographic evidences of bone resorption 
were divided into three groups according to Joo and Lee’s 
study [19].
Following surgery, excised tissue specimens were immedi-
ately placed on liquid nitrogen and subsequently frozen (-70°C).
Protein isolation and western blotting
For western blotting, as previously described by Kim et al. [20] 
frozen tissues were homogenized in RIPA lysis buffer (10 mM 
EDTA, 0.15 M NaCl) with 1:30 diluted protease inhibitor cock-
tail (Roche, Mannheim, Germany) according to Cho et al.’s 
method [21]. Protein concentrations of supernatant were rou-
tinely determined by a Bradford protein assay (Quick Start
TM, 
BIO-RAD, Hercules, USA) using bovine serum albumin as stan-
dard.
The quantification analysis of IL-4, IFN-g and TIMP-2 ex-
pression was performed using a densitometer (Scion Image 
b 4.02, Scion Corporation, Frederick, USA). After normaliza-
tion to b-actin (Abcam, Edinburgh, UK) in each sample, level 
of IL-4, IFN-g and TIMP-2 were expressed as a ratio of IL-4, 
IFN-g, or TIMP-2/b-actin and the differences of density be-
tween the three groups were determined.
Statistical analysis of the western blot results
All data were presented as means ± SD and results were sta-
tistically analyzed. The IL-4, IFN-g and TIMP-2 levels among 
the 3 groups were compared using one-way ANOVA followed 
by Tukey’s test. A P-value < 0.05 was considered to be statisti-
cally significant.
RESULTS
Both the chronic periodontitis group and the chronic peri-
odontitis with type 2 DM group showed the expression of IL-
4, IFN-g and TIMP-2 in all samples.
IL-4 specific antibodies were used to detect the cytokine in Journal of Periodontal
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the tissues (Figs. 1A and B). Representative western blot data 
(Fig. 1A) detected about an 18 kDa molecular weight of IL-4 in 
all three groups. The expression levels of b-actin were also 
measured by anti-b-actin specific western blot analysis. In 
order to quantify the level of IL-4 expression in the groups, 
the expression levels of IL-4 in each sample were measured 
by densitometer. Then IL-4 expression levels were normal-
ized by b-actin (ratio of IL-4/b-actin).
The mean amount of IL-4 expression (ratio of IL-4/b-actin) 
were 0.911 ± 0.131 in Group 1, 0.664 ± 0.155 in Group 2, and 
0.648 ± 0.177 in Group 3. There was a significant difference 
between Groups 1 and 3, and between Groups 2 and 3, but 
there was no statistically significant difference (P < 0.05) be-
tween Groups 1 and 2.
The comparison of IFN-g expression levels were also made 
by western blot analysis using IFN-g specific antibody (Fig. 
2A). The levels of IFN-g expression which detected a molecu-
lar weight within the range of 20-25 kDa were also quantified 
with b-actin normalization (Fig. 2B). The mean amounts of 
IFN-g expression (ratio of IFN-g/b-actin) were 0.465 ± 0.120 in 
Group 1, 0.553 ± 0.161 in Group 2 and 0.664 ± 0.160 in Group 3. 
There was a significant difference between Groups 1 and 3 
(P < 0.05).
In this study, the molecular weight of TIMP-2 was identi-
fied as 21 kDa size in western blot analysis (Fig. 3A). The mean 
value of TIMP-2 expression (ratio of TIMP-2/b-actin) was 
0.407 ± 0.080 for Group 1, 0.559 ± 0.158 for Group 2 and 0.649 ± 
0.165 for Group 3. There was a significant difference between 
Groups 1 and 3, and between Groups 2 and 3 (P < 0.05).
DISCUSSION
The association between DM and periodontitis has long 
been discussed with conflicting conclusions. Current studies 
tend to support a higher incidence and severity of periodon-
titis in patients with DM. It has been shown that diabetes up-
regulates the production of inflammatory cytokines and 
chemokines [22], leading to increased inflammation, tissue 
damage, and apoptosis in patients who have periodontitis [23].
The immune response against periodontopathic bacteria is 
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Figure 1.  (A) Interleukin (IL)-4 western blot analysis showing 4 rep-
resentative samples in each group. IL-4 levels were quantified on the 
basis of b-actin levels. IL-4 corresponding to molecular weight 18 kDa 
was shown to be expressed in all samples including healthy gingiva, 
and the expression levels of IL-4 were decreased in order of Groups 
1-3. (B) Graphics showing the average amounts (ratio of IL-4/b-actin) 
and standard deviation of IL-4 level in Groups 1-3. In the healthy gin-
gival tissues (Group 1), the levels of IL-4 were significantly decreased 
as compared to Groups 1 and 2 (P < 0.05). * Significant difference be-
tween Groups 1 and 3 (P < 0.05). 
† Significant difference between Groups 
1 and 2 (P < 0.05). Group 1: healthy gingiva from systemically healthy 
individuals, Group 2: inflamed gingiva from patients with chronic 
periodontitis, Group 3: inflamed gingiva from patients with chronic 
periodontitis and type 2 diabetes mellitus.
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Figure 2.  (A) Interferon (IFN)-g western blot analysis showing 4 rep-
resentative samples in each group. IFN-g levels were quantified on 
the basis of b-actin levels. IFN-g corresponding to molecular weight 
20-25 kDa was shown to be expressed in all samples including healthy 
gingiva. The expression levels of IFN-g increased in order of Groups 
1-3. (B) Graphics showing the average amounts (ratio of IFN-g/b-ac-
tin) and standard deviation of IFN-g level in Groups 1-3. In the in-
flamed gingiva (with or without diabetes, Groups 2 and 3), the levels 
of IFN-g were higher than those in healthy gingiva. * Significant 
difference between Groups 1 and 3 (P < 0.05). Group 1: healthy gin-
giva from systemically healthy individuals, Group 2: inflamed gin-
giva from patients with chronic periodontitis, Group 3: inflamed 
gingiva from patients with chronic periodontitis and type 2 diabetes 
mellitus.Journal of Periodontal
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regulated by the balance between cytokines produced by Th1 
and Th2 cells. Th1 cells regulate a cell-mediated-type immune 
response, and Th2 cells regulate a humoral-type immune re-
sponse. In addition, each subset can regulate the function of 
the other. The typical secretory products of Th1 cells are IL-2, 
IL-12, TNF-b, and IFN-g; those of Th2 cells are IL-4, IL-5, IL-6, 
IL-10, and IL-13 [8].
IL-4 is a pleiotropic cytokine that inhibits Th1 cells while 
stimulating a Th2-type of immune response. IL-4 has been 
shown to inhibit the IL-1 induction of MMP-3 expression in 
human skin fibroblasts [10]. IL-4 also inhibits the IL-1-induced 
expression of MMP-3 mRNA and protein in human gingival 
fibroblast isolated from patients with periodontitis. In a re-
cent study, Salmon-Ehr et al. [24] demonstrated that IL-4, a 
pleiotropic cytokine, was able to activate connective tissue 
cells and stimulate accumulation of the extracellular matrix 
macromolecules. They concluded that IL-4 was implicated in 
wound healing.
Until now, few studies have reported the expression of IL-4 
in the periodontitis patient to be associated with type 2 DM. 
In this study the quantitative analysis of the IL-4 level showed 
that IL-4 expression was rather decreased in inflamed gingi-
va associated with type 2 DM as compared to healthy gingiva 
and inflamed gingiva of the systemically healthy patient, and 
the difference was statistically significant (P < 0.05). IL-4 in-
hibits the secretion of PGE2 and cytokines by macrophage, 
and suppresses the synthesis of proinflammatory cytokines 
which induces inflammation, and suggests that the absence 
of IL-4 induces periodontal disease. This result indicates that 
IL-4 inhibits inflammatory response in disease progression 
in chronic periodontitis in type 2 DM patients and plays a 
role in decreased inflammatory response with bone resorp-
tion in patients with this systemic disease.
IFN-g, released during the early and late stages of the im-
mune response by natural killer cells and activated T cells, 
respectively, regulates several aspects of the immune response 
[25]. In addition, it mediates the host defense against infection 
and is a potent activator of mononuclear phagocytes. In our 
data, the level of IFN-g was increased in inflamed gingiva. The 
amounts of IFN-g expression were higher in chronic perio-
dontitis patients with type 2 DM as compared to healthy gin-
giva from a systemically healthy subjects, and the difference 
was statistically significant (P < 0.05). In some studies, IFN-g 
seemed to be the predominant cytokine produced by T cells 
in periodontal diseases, and an enhancement of IFN-g-pro-
ducing cells was correlated with the progression of disease 
[12]. Gorska et al. [26] reported that the concentration of IFN-
g was significantly higher in serum samples and gingival tis-
sue biopsies from periodontitis patients than from healthy 
controls. Our data also demonstrated that the total amount 
of cytokine IFN-g in active sites in patients with the progres-
sion of periodontitis is significantly higher than in inactive 
sites. IFN-g is a inflammatory cytokine associated with inflam-
mation, tissue destruction, bone resorption and the produc-
tion of matrix metalloproteinases and PGE2. The high expres-
sion of these cytokines in chronic periodontitis patients may 
be a marker of continuous Th1 response against bacterial 
pathogens colonized in gingival tissue, suggesting that the 
Th1 response plays a destructive role in the periodontium.
The pro-inflammatory cytokines stimulate cells of the host 
to produce a number of MMPs, which are eventually respon-
sible for degradation of periodontal connective tissues in the 
pathogenesis of periodontitis. TIMPs, which consist of four 
members, TIMP-1, 2, 3, and 4, have many basic similarities, but 
they exhibit structural and biochemical differences. TIMP-2 
is able to bind noncovalently to the latent proform of MMP-
2 away from its active sites, thereby preventing its activation 
and inhibiting enzyme activity [17]. An imbalance between 
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Figure 3.  (A) Tissue inhibitor of matrix metalloproteinases-2 (TIMP-
2) western blot analysis showing 4 representative samples in each 
group. TIMP-2 levels were quantified on the basis of b-actin levels. 
TIMP-2 corresponding to molecular weight 21 kDa was shown to be 
expressed in all samples including healthy gingiva. The expression 
levels of TIMP-2 were higher in patients with type 2 diabetes melli-
tus (DM) than in control healthy subjects. (B) Graphics showing the 
average amounts (ratio of TIMP-2/b-actin) and standard deviation 
of TIMP-2 level in Groups 1-3. In the inflamed gingiva (with or with-
out diabetes, Groups 2 and 3), the levels of TIMP-2 were higher than 
those in healthy gingiva (P < 0.05). * Significant difference between 
Groups 1 and 3 (P < 0.05). 
† Significant difference between Groups 1 
and 2 (P < 0.05). Group 1: healthy gingiva from systemically healthy 
individuals, Group 2: inflamed gingiva from patients with chronic 
periodontitis, Group 3: inflamed gingiva from patients with chronic 
periodontitis and type 2 DM.Journal of Periodontal
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MMPs and TIMPs synthesis can promote destruction of the 
ECM components [16]. The balance between MMP-2 and 
TIMP-2 expression changes, and several studies have found 
that during periodontal disease, there is an imbalance of pro-
teinases/inhibitors in favor of proteinases.
Larivee et al. [27] found the concentration of collagenase in-
hibitors to be higher in healthy gingiva than in periodontitis-
affected sites. In this study, the quantitative analysis of TIMP-
2 levels showed that TIMP-2 expression was rather increased 
in inflamed gingiva with or without type 2 DM as compared 
to healthy gingiva, and the difference was statistically signifi-
cant. This might suggest that the host is producing TIMP-2 
as the anti-proteolytic shield to overcome and regulate the 
tissue-destructive effects of MMPs in gingival tissues.
In conclusions, this study demonstrated that IFN-g and 
TIMP-2 expression levels in human gingival tissue have a 
positive correlation with the bone resorption process in in-
flamed tissue and inflamed tissue associated with type 2 DM. 
This suggests that IFN-g and TIMP-2 may be involved in the 
alveolar bone resorptive process of periodontal inflammation 
associated with type 2 DM. On the other hand, tissue with 
chronic periodontitis associated with type 2 DM showed sig-
nificantly decreased IL-4 levels compared to healthy gingiva 
and non-diabetic inflamed gingiva. This suggests that IL-4 
may be involved in the retrogression of periodontal inflam-
mation associated with type 2 DM.
Finally, it seems that more studies are needed to investigate 
the effect and interrelationship between IL-4, IFN-g, TIMP-2, 
and other cytokines that affect the progression of periodon-
tal disease at a higher level. Further studies will contribute to 
the development of disease diagnosis methods and treat-
ment modalities.
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